PROCEPT Biorobotics presents positive Aquablation data at American Urological Association annual meeting

Posted in Medical Device by Medtech[y] Staff

May 21, 2018 • 3 min read

Yesterday, during the American Urological Association Annual Meeting (AUA), PROCEPT Biorobotics announced early data from the global Phase III WATER II (Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue) Study showing the achievement of primary safety and efficacy endpoints for Aquablation in the treatment of benign prostatic hyperplasia (BPH). ​...

Migraine Drug Could Add 10% to Amgen's Revenue

Posted in Biotech by Medtech[y] Staff

May 21, 2018 • 2 min read

On CNBC's "Power Lunch," a Wall Street analyst stated that Amgen's recently approved migraine drug, Aimovig, could become a $2 billion business in the next five years. That revenue would equate to a 10 percent increase to Amgen's revenue as the drug provides a huge unmet need for adults who deal with migraines. ...